These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 590344)

  • 1. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.
    Scatton B
    Eur J Pharmacol; 1977 Dec; 46(4):363-9. PubMed ID: 590344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat.
    Lindefors N; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1986 Oct; 129(3):401-4. PubMed ID: 3780852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
    Scatton B; Bischoff S; Dedek J; Korf J
    Eur J Pharmacol; 1977 Aug; 44(4):287-92. PubMed ID: 19266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administration.
    Reynolds LM; Dyer RG; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Mar; 35(3):170-4. PubMed ID: 6132975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific effect of haloperidol on dopamine turnover in the frontal cortex.
    Laduron P; de Bie K; Leysen J
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):183-5. PubMed ID: 834317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with 1-sulpiride and haloperidol on central dopamine turnover evaluated in dopamine cell body and nerve terminal-rich areas.
    Agnati LF; Andersson K; Fuxe K; Benfenati F; Cortelli P; D'Alessandro R; Ogren SO
    Adv Biochem Psychopharmacol; 1980; 24():75-80. PubMed ID: 7405679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
    Satoh H; Kuwaki T; Shirakawa K; Kohjimoto Y; Ono T; Shibayama F; Nomura Y
    Jpn J Pharmacol; 1987 Aug; 44(4):393-403. PubMed ID: 3682405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats.
    Guinetdinov RR; Bogdanov MB; Pogorelov VM; Kudrin VS; Rayevsky KS
    Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system.
    Bartholini G
    J Pharm Pharmacol; 1976 May; 28(5):429-33. PubMed ID: 6752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain.
    Matsumoto T; Uchimura H; Hirano M; Kim JS; Yokoo H; Shimomura M; Nakahara T; Inoue K; Oomagari K
    Eur J Pharmacol; 1983 Apr; 89(1-2):27-33. PubMed ID: 6861888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Waldmeier PC; Maître L
    J Neurochem; 1976 Aug; 27(2):589-97. PubMed ID: 989496
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation and metabolism of dopamine in nine areas of the rat brain: modifications by haloperidol.
    Westerink BH; Bosker FJ; Wirix E
    J Neurochem; 1984 May; 42(5):1321-7. PubMed ID: 6707637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the significance of regional dopamine metabolism in the rat brain for the classification of centrally acting drugs.
    Westerink BH; Lejeune B; Korf J; Van Praag HM
    Eur J Pharmacol; 1977 Mar; 42(2):179-90. PubMed ID: 844497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.